Clinical Trial Endpoints in Cancer Research: Four Terms You Should Know
Overall Response Rate of 76% in Advanced Melanoma Patients
Differential Activity of Nivolumab, Pembrolizumab and MPDL3280A according to the Tumor Expression of Programmed Death-Ligand-1 (PD-L1): Sensitivity Analysis of Trials in Melanoma, Lung and Genitourinary Cancers | PLOS ONE
Confirmed ORR and Median DOR | ENHERTU® (fam-trastuzumab deruxtecan-nxki)
ORR (Objective Response Rate) and related statistics – Part 1
Overall Response Rate (ORR) as Function of Baseline C-reactive Protein... | Download Scientific Diagram
Overall response rate (ORR) and clinical benefit analysis of sorafenib... | Download Scientific Diagram
Response rate of anticancer drugs approved by the Food and Drug Administration based on a single-arm trial | BMC Cancer | Full Text